Lifco

• Lifco förvärvar Maxlight i Storbritannien

  Announcement4d agoIssuer IR via MFN (press rooms)Source

• Delårsrapport januari-september 2026

  interim-report7d agoIssuer IR via MFN (press rooms)Source

  REPORT SUMMARY · neutral

  The announcement is titled “Delårsrapport januari-september 2026,” identifying it as Lifco’s interim report for January through September 2026, published on 23 October 2026. The available record contains no financial figures, results commentary, outlook or guidance, capital actions, or named transactions, so the report’s financial direction and material developments cannot be assessed from this evidence.

  • Issuer: Lifco.
  • Document type: interim report.
  • Reporting period named in the title: January–September 2026.
  • Publication date: 23 October 2026.
  • No substantive financial, outlook, or capital-action details are included in the available record.

• Lifco förvärvar Hega Medical i Tyskland

  Announcement15d agoIssuer IR via MFN (press rooms)Source

• Lifco publicerar rapporten för tredje kvartalet 23 oktober

  interim-report2026-09-29Issuer IR via MFN (press rooms)Source

  REPORT SUMMARY · neutral

  The release is a procedural notice from Lifco confirming publication of its Q3 interim report on 23 oktober, issued via the issuer's IR channel on MFN press rooms. No figures, outlook statements, guidance changes, or capital actions are present in the supplied evidence — only the scheduling detail. As such, the announcement confirms an upcoming report, with the substantive content (results, segment KPIs, leverage, M&A commentary) not yet disclosed in this record.

  • Filing type: interim-report (Q3), per the record metadata.
  • Announcement publisher: Lifco, distributed via MFN press rooms as Issuer IR.
  • Scheduled report publication date: 23 oktober, per the headline.
  • Announcement timestamp: 2026-09-29T08:00:00Z, roughly four weeks before the scheduled release window.
  • No KPIs, balance-sheet items, cash flow, guidance, or capital-actions disclosed in the supplied evidence — only the scheduling notice itself.

• Lifco förvärvar Micronova i Italien

  Announcement2026-09-28Issuer IR via MFN (press rooms)Source

• Nya affärsområdeschefer i Lifco

  Announcement2026-09-08Issuer IR via MFN (press rooms)Source

• Lifco emitterar obligationslån om 750 MSEK

  Announcement2026-08-20Issuer IR via MFN (press rooms)Source

• Lifco förvärvar Mozelt i Tyskland

  Announcement2026-07-31Issuer IR via MFN (press rooms)Source

1 / 3→

• OMX disclosed short books overlap with 5% ownership crossings and PDMR clustering on the same namesmoderate confidence

  Detected via 3 evidence records

• Disclosed short concentration in cyclical and consumer-discretionary names with conflicting ownership signalsmoderate confidence

  Detected via 2 evidence records

• Disclosed short book concentrated across OMXS30 with SKF as live long-only vs short battlegroundmoderate confidence

  Detected via 2 evidence records

• FI-disclosed short book tilts to cyclicals, industrials, and consumer discretionaryhigh confidence

  Detected via 2 evidence records

• Disclosed short book concentrated in OMXS30 industrial/consumer names, with live short/long offsets at SKF and H&Mmoderate confidence

• Addtechvia Two-way institutional positioning across OMXS30 large caps: BlackRock passive rotation plus disclosed short clustering
• Swedbankvia Company purchases, disclosed shorts and rate sensitivity form separate cohorts
• Danske Bankvia Company purchases, disclosed shorts and rate sensitivity form separate cohorts
• Tobiivia Disclosed short books cluster in consumer-discretionary, hygiene/packaging and industrial cyclicals
• Nordeavia Company purchases, disclosed shorts and rate sensitivity form separate cohorts
• Avanzavia Disclosed short exposure forms a broad OMXS30 overlay
• Vitecvia Embracer-led disclosed short book with cross-sector tail and multi-tape pressure overlap on H&M
• Sandvikvia Company-insider purchases coincide with negative 14-day returns